TIDMSTX TIDMSTXW

RNS Number : 1931H

Shield Therapeutics PLC

15 August 2016

Shield Therapeutics plc

("Shield" or the "Company")

Notice of Interim Results

London, UK, 15 August 2016. Shield Therapeutics plc (LSE:STX), a specialty pharmaceutical company focused on secondary care, announces it will report its interim results for the six months ended 30 June 2016 on Tuesday 20 September 2016.

Carl Sterritt, Chief Executive Officer, Richard Jones, Chief Financial Officer, and Paul Steckler, VP Commercial Operations, will host a presentation and live conference call for analysts at 11.00am BST on the morning of results in the Guildhall Room at 85 Gresham Street, London, EC2V 7NQ.

- Ends -

For further information please contact:

 
 Shield Therapeutics plc                +44 (0)191 511 8507 
 Carl Sterritt, Chief Executive 
  Officer 
  Richard Jones, Chief Financial 
  Officer 
 
 NOMAD 
  Liberum Capital Limited 
  Christopher Britton 
  Steve Pearce                          +44 (0)20 3100 2222 
 Financial PR Advisor                   +44 (0)203 709 5700 
  Consilium Strategic Communications     shieldtherapeutics@consilium-comms.com 
 Mary-Jane Elliott 
  Matthew Neal 
  Lindsey Neville 
  Hendrik Thys

About Shield Therapeutics plc

Shield Therapeutics is a specialty pharmaceutical company focused on the commercialisation and development of late-stage, hospital-focused pharmaceuticals which address areas of unmet medical need. The Company has a marketed product, Feraccru(R), for the treatment of iron deficiency anaemia (IDA). In addition, the Company is developing PT20, a late-stage pharmaceutical for the treatment of systemic phosphate accumulation (hyperphosphatemia). Shield Therapeutics, headquartered in London, is listed on LSE's AIM under the ticker STX. For more information please visit www.shieldtherapeutics.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORBBGDICBBBGLU

(END) Dow Jones Newswires

August 15, 2016 07:22 ET (11:22 GMT)

Shield Therapeutics (LSE:STX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Shield Therapeutics Charts.
Shield Therapeutics (LSE:STX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Shield Therapeutics Charts.